|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
HORMONES AND SIGNALING
activity
Departments of Medicine and Physiology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia
Submitted 20 January 2004 ; accepted in final form 28 July 2004
We have previously shown that endogenous IGF-I regulates human intestinal smooth muscle cell proliferation by activation of phosphatidylinositol 3 (PI3)-kinase- and Erk1/2-dependent pathways that jointly regulate cell cycle progression and cell division. Whereas insulin-like growth factor-I (IGF-I) stimulates PI3-kinase-dependent activation of Akt, expression of a kinase-inactive Akt did not alter IGF-I-stimulated proliferation. In other cell types, Akt-dependent phosphorylation of glycogen synthase kinase-3
(GSK-3
) inhibits its activity and its ability to stimulate apoptosis. The aim of the present study was to determine whether endogenous IGF-I regulates Akt-dependent GSK-3
phosphorylation and activity and whether it regulates apoptosis in human intestinal muscle cells. IGF-I elicited time- and concentration-dependent GSK-3
phosphorylation (inactivation) that was measured by Western blot analysis using a phospho-specific GSK-3
antibody. Endogenous IGF-I stimulated GSK-3
phosphorylation and inhibited GSK-3
activity (measured by in vitro kinase assay) in these cells. IGF-I-dependent GSK-3
phosphorylation and the resulting GSK-3
inactivation were mediated by activation of a PI3-kinase-dependent, phosphoinositide-dependent kinase-1 (PDK-1)-dependent, and Akt-dependent mechanism. Deprivation of serum induced
-catenin phosphorylation, increased in caspase 3 activity, and induced apoptosis of muscle cells, which was inhibited by either IGF-I or a GSK-3
inhibitor. Endogenous IGF-I inhibited
-catenin phosphorylation, caspase 3 activation, and apoptosis induced by serum deprivation. IGF-I-dependent inhibition of apoptosis, similar to GSK-3
activity, was mediated by a PI3-kinase-, PDK-1-, and Akt-dependent mechanism. We conclude that endogenous IGF-I exerts two distinct but complementary effects on intestinal smooth muscle cell growth: it stimulates proliferation and inhibits apoptosis. The growth of intestinal smooth muscle cells is regulated jointly by the net effect of these two processes.
phosphoinositidol 3-kinase; phosphoinositide-dependent kinase-1; Akt; proliferation
This article has been cited by other articles:
![]() |
K. B. Hazelgrove, R. S. Flynn, L.-Y. Qiao, J. R. Grider, and J. F. Kuemmerle Endogenous IGF-I and {alpha}v{beta}3 integrin ligands regulate increased smooth muscle growth in TNBS-induced colitis Am J Physiol Gastrointest Liver Physiol, June 1, 2009; 296(6): G1230 - G1237. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. A. Ivory, L. E. Wallace, D.-M. McCafferty, and D. L. Sigalet Interleukin-10-independent anti-inflammatory actions of glucagon-like peptide 2 Am J Physiol Gastrointest Liver Physiol, December 1, 2008; 295(6): G1202 - G1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, F. Tan, and C. J. Thiele Inactivation of glycogen synthase kinase-3 contributes to brain-derived neutrophic factor/TrkB-induced resistance to chemotherapy in neuroblastoma cells Mol. Cancer Ther., December 1, 2007; 6(12): 3113 - 3121. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Kuemmerle Occupation of {alpha}vbeta3-integrin by endogenous ligands modulates IGF-I receptor activation and proliferation of human intestinal smooth muscle Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1194 - G1202. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Dong, L. B. Esberg, Z. K. Roughead, J. Ren, and J. T. Saari Increased contractility of cardiomyocytes from copper-deficient rats is associated with upregulation of cardiac IGF-I receptor Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H78 - H84. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |